These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26181421)

  • 21. Serial investigation of PTPN11 mutation in nonhematopoietic tissues in a patient with juvenile myelomonocytic leukemia who was treated with unrelated cord blood transplantation.
    Hiramoto R; Imamura T; Muramatsu H; Wang X; Kanayama T; Zuiki M; Yoshida H; Moroto M; Fujiki A; Chiyonobu T; Osone S; Ishida H; Kojima S; Hosoi H
    Int J Hematol; 2015 Dec; 102(6):719-22. PubMed ID: 26440969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay.
    Tanaka M; Takahashi Y; Xu Y; Yoshida N; Yoshimi A; Villalobos IB; Hama A; Nishio N; Hidaka H; Wang Y; Yagasaki H; Kojima S
    Leuk Res; 2008 Jul; 32(7):1036-42. PubMed ID: 18164384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noonan Syndrome-related Myeloproliferative Disorder Occurring in the Neonatal Period: Case Report and Literature Review.
    Hoshino Y; Moriya K; Mitsui-Sekinaka K; Hashimoto Y; Nakayama S; Sajiki D; Muramatsu H; Hagiwara H; Suzuki S; Sekinaka Y; Wakamatsu H; Kawaguchi H; Imai K
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e176-e179. PubMed ID: 38132703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic findings in skin biopsy in a JMML rash: a case report and review of literature.
    Gupta RK; Qureshi A; Choi JK
    Pediatr Dev Pathol; 2014; 17(2):130-3. PubMed ID: 24555839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Juvenile myelomonocytic leukemia presenting with coexistent cytomegalovirus infection--a case report.
    Prabhu SB; Gupta R; Seth R
    J Pediatr Hematol Oncol; 2010 May; 32(4):e153-4. PubMed ID: 20445410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)].
    Koike K; Matsuda K
    Rinsho Ketsueki; 2013 Jun; 54(6):538-44. PubMed ID: 23823092
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.
    Jenkins C; Luty SB; Maxson JE; Eide CA; Abel ML; Togiai C; Nemecek ER; Bottomly D; McWeeney SK; Wilmot B; Loriaux M; Chang BH; Tyner JW
    Sci Signal; 2018 Jul; 11(539):. PubMed ID: 30018082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelodysplastic and myeloproliferative disorders of childhood.
    Hasle H
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):598-604. PubMed ID: 27913534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.
    Tartaglia M; Niemeyer CM; Fragale A; Song X; Buechner J; Jung A; Hählen K; Hasle H; Licht JD; Gelb BD
    Nat Genet; 2003 Jun; 34(2):148-50. PubMed ID: 12717436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia.
    Pasupuleti SK; Chao K; Ramdas B; Kanumuri R; Palam LR; Liu S; Wan J; Annesley C; Loh ML; Stieglitz E; Burke MJ; Kapur R
    Mol Ther; 2023 Apr; 31(4):986-1001. PubMed ID: 36739480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
    Koike K; Matsuda K
    Br J Haematol; 2008 May; 141(5):567-75. PubMed ID: 18422786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia.
    Matsuda K; Nakazawa Y; Iwashita C; Kurata T; Hirabayashi K; Saito S; Tanaka M; Yoshikawa K; Yanagisawa R; Sakashita K; Sasaki S; Honda T; Koike K
    Leukemia; 2014 Jul; 28(7):1545-8. PubMed ID: 24496301
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.
    Xu D; Liu X; Yu WM; Meyerson HJ; Guo C; Gerson SL; Qu CK
    J Exp Med; 2011 Sep; 208(10):1977-88. PubMed ID: 21930766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia.
    Doisaki S; Muramatsu H; Shimada A; Takahashi Y; Mori-Ezaki M; Sato M; Kawaguchi H; Kinoshita A; Sotomatsu M; Hayashi Y; Furukawa-Hibi Y; Yamada K; Hoshino H; Kiyoi H; Yoshida N; Sakaguchi H; Narita A; Wang X; Ismael O; Xu Y; Nishio N; Tanaka M; Hama A; Koike K; Kojima S
    Blood; 2012 Aug; 120(7):1485-8. PubMed ID: 22753870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurofibromatosis type 1 diagnosed in a child based on multiple juvenile xanthogranulomas and juvenile myelomonocytic leukemia.
    Jans SR; Schomerus E; Bygum A
    Pediatr Dermatol; 2015; 32(1):e29-32. PubMed ID: 25516272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline PTPN11 mutation affecting exon 8 in a case of syndromic juvenile myelomonocytic leukemia.
    Prontera P; Pantaleoni F; Martinelli S; Mastrodicasa E; Stangoni G; Barboni G; Tartaglia M; Aversa F; Donti E
    Leuk Res; 2011 Mar; 35(3):e13-4. PubMed ID: 21106241
    [No Abstract]   [Full Text] [Related]  

  • 37. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
    Dong L; Yu WM; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT; Qu CK
    Nature; 2016 Nov; 539(7628):304-308. PubMed ID: 27783593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia.
    Poetsch AR; Lipka DB; Witte T; Claus R; Nöllke P; Zucknick M; Olk-Batz C; Fluhr S; Dworzak M; De Moerloose B; Starý J; Zecca M; Hasle H; Schmugge M; van den Heuvel-Eibrink MM; Locatelli F; Niemeyer CM; Flotho C; Plass C
    Epigenetics; 2014 Sep; 9(9):1252-60. PubMed ID: 25147919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.
    Yoshimi A; Kojima S; Hirano N
    Paediatr Drugs; 2010; 12(1):11-21. PubMed ID: 20034338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myelodysplastic syndrome in children].
    Yoshimi-Noellke A
    Rinsho Ketsueki; 2009 Oct; 50(10):1560-9. PubMed ID: 19915367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.